These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 691945)

  • 21. [The prophylactic and therapeutic use of piracetam in reproduced myocardial infarct].
    Kresiun VI; Kravchenko LS; Kadyrova LL
    Farmakol Toksikol; 1990; 53(2):29-31. PubMed ID: 2369949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Emoxipin in reperfusion of ischemic myocardium in dogs: effects on infarct size and plasma creatine kinase activity].
    Konorev EA; Polumiskov VIu; Avilova OA; Golikova AP
    Biull Eksp Biol Med; 1990 Sep; 110(9):252-4. PubMed ID: 2268707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of intravenous and intra-arterial methylprednisolone in cardiogenic shock.
    Shatney CH; Dietzman RH; Lillehei RC
    Adv Shock Res; 1980; 3():123-32. PubMed ID: 7304313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of serotonin (5HT2) receptor blockade in myocardial reperfusion injury: effects of LY53857 in a canine model of myocardial infarction.
    Simpson PJ; Schelm JA; Jakubowski JA; Smallwood JK
    J Pharmacol Exp Ther; 1991 Sep; 258(3):979-85. PubMed ID: 1653847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limitation of infarct size by beta blockers and its potential role for prognosis.
    Hjalmarson A; Herlitz J
    Circulation; 1983 Jun; 67(6 Pt 2):I68-71. PubMed ID: 6133646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II fails to induce preconditioning in vivo--the protective role of myocardial stretch due to pressure overload.
    Iliodromitis EK; Vlahakos DV; Bofilis E; Karavolias GK; Tasouli A; Kremastinos DT
    Can J Cardiol; 2002 Jan; 18(1):34-42. PubMed ID: 11826327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of lidocaine and pyromecaine on the size of an experimental myocardial infarct].
    Goldshteĭne GKh; Tsorin IB; Chichkanov GG
    Biull Eksp Biol Med; 1986 Feb; 101(2):177-9. PubMed ID: 3947734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superoxide dismutase plus catalase therapy delays neither cell death nor the loss of the TTC reaction in experimental myocardial infarction in dogs.
    Tanaka M; Richard VJ; Murry CE; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 1993 Apr; 25(4):367-78. PubMed ID: 8340930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of intravenous nitroglycerin on the hemodynamics and the degree of ischemia in experimental myocardial infarct].
    Stepina NI; Revenko VM
    Farmakol Toksikol; 1982; 45(4):46-8. PubMed ID: 6813140
    [No Abstract]   [Full Text] [Related]  

  • 30. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization.
    Skyschally A; Haude M; Dörge H; Thielmann M; Duschin A; van de Sand A; Konietzka I; Büchert A; Aker S; Massoudy P; Schulz R; Erbel R; Heusch G
    Circulation; 2004 May; 109(19):2337-42. PubMed ID: 15117838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylprednisolone in AMI.
    Klein L
    Circulation; 1979 Nov; 60(5):1197. PubMed ID: 487551
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of a combined use of propranolol and nifedipine on experimental myocardial infarct size].
    Wu GL; Chen SG; Jia DL; Cao EH; Zhang DM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Oct; 6(5):342-5. PubMed ID: 6241084
    [No Abstract]   [Full Text] [Related]  

  • 34. Infarct size reduction: a review of clinical trials.
    Fitzsimons TJ
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S34-7. PubMed ID: 2483230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation.
    Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):619-24. PubMed ID: 2831348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inability of fructose 1,6-diphosphate to reduce myocardial infarct size.
    Brown EJ; Erburu L; Kloner RA
    J Med; 1987; 18(1):43-53. PubMed ID: 3474341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of methylprednisolone sodium succinate on experimental pulmonary contusion.
    Franz JL; Richardson JD; Grover FL; Trinkle JK
    J Thorac Cardiovasc Surg; 1974 Nov; 68(5):842-4. PubMed ID: 4607745
    [No Abstract]   [Full Text] [Related]  

  • 38. [A preliminary study of treatment of experimental systemic (cutaneous-visceral) loxoscelism in the rabbit with injectable methyl prednisolone (author's transl)].
    Schenone H; Letonja T; Schenone D
    Bol Chil Parasitol; 1979; 34(3-4):84-6. PubMed ID: 549579
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of methylprednisolone on collagen biosynthesis in healing acute myocardial infarction.
    Vivaldi MT; Eyre DR; Kloner RA; Schoen FJ
    Am J Cardiol; 1987 Aug; 60(4):424-5. PubMed ID: 3618516
    [No Abstract]   [Full Text] [Related]  

  • 40. Lysosomal mechanisms in production of tissue damage during myocardial ischemia and the effects of treatment with steroids.
    Am Heart J; 1976 Mar; 91(3):394-7. PubMed ID: 1258738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.